The Asia Pacific Antimicrobial Suture Market is projected to witness market growth of 4.1% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Antimicrobial Suture Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $28.42 millions by 2031. The Japan market is showcasing a CAGR of 3.5% during 2024-2031. Additionally, the India market would register a CAGR of 4.7% during 2024-2031.
Orthopedic surgeries, such as joint replacements, fracture repairs, and ligament reconstructions, often involve antimicrobial sutures. The complex nature of these surgeries and the risk of postoperative infections make antimicrobial sutures crucial for preventing complications and promoting healing.
Additionally, in cardiovascular procedures, including heart surgeries and vascular repairs, antimicrobial sutures are employed to minimize the risk of infections. These sutures help maintain sterile conditions and prevent infections that could compromise the success of the surgery and the patient’s overall health.
The high volume of surgeries in Australia leads to an increased demand for antimicrobial sutures. Hospitals and surgical centers need effective solutions to prevent infections in a large number of surgical cases, boosting the market for these specialized sutures. According to the Australian Government, in 2022-23, 735,500 patients were admitted for surgery from public hospital elective surgery waiting lists - an 18% increase compared with 2021-22. General surgery was the most common surgical specialty (20%), followed by Urological surgery (15%).
Based on Type, the market is segmented into Absorbable and Non absorbable. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Antimicrobial Suture Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $28.42 millions by 2031. The Japan market is showcasing a CAGR of 3.5% during 2024-2031. Additionally, the India market would register a CAGR of 4.7% during 2024-2031.
Orthopedic surgeries, such as joint replacements, fracture repairs, and ligament reconstructions, often involve antimicrobial sutures. The complex nature of these surgeries and the risk of postoperative infections make antimicrobial sutures crucial for preventing complications and promoting healing.
Additionally, in cardiovascular procedures, including heart surgeries and vascular repairs, antimicrobial sutures are employed to minimize the risk of infections. These sutures help maintain sterile conditions and prevent infections that could compromise the success of the surgery and the patient’s overall health.
The high volume of surgeries in Australia leads to an increased demand for antimicrobial sutures. Hospitals and surgical centers need effective solutions to prevent infections in a large number of surgical cases, boosting the market for these specialized sutures. According to the Australian Government, in 2022-23, 735,500 patients were admitted for surgery from public hospital elective surgery waiting lists - an 18% increase compared with 2021-22. General surgery was the most common surgical specialty (20%), followed by Urological surgery (15%).
Based on Type, the market is segmented into Absorbable and Non absorbable. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Conmed Corporation
- Smith & Nephew plc
- Demetech Corporation
- Medtronic PLC
- Braun Melsungen AG
- W.L. Gore & Associates, Inc.
- Boston Scientific Corporation
- Johnson & Johnson
- Peters Surgical
- Stryker Corporation
Market Report Segmentation
By Type
- Absorbable
- Non absorbable
By End User
- Hospitals
- Clinics
- Others
By Country
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Antimicrobial Suture Market by Type
Chapter 5. Asia Pacific Antimicrobial Suture Market by End User
Chapter 6. Asia Pacific Antimicrobial Suture Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Conmed Corporation
- Smith & Nephew plc
- Demetech Corporation
- Medtronic PLC
- B. Braun Melsungen AG
- W. L. Gore & Associates, Inc.
- Boston Scientific Corporation
- Johnson & Johnson
- Peters Surgical
- Stryker Corporation
